Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 3/20 | 0.34 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.34 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22514626 | 1.00 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10PRKDCPGR | |
| SCHEMBL22514354 | 0.98 | PLA2G2A (0.33) | PLA2G2APLA2G4APLA2G10PRKDCPGR | |
| SCHEMBL22514607 | 0.98 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10PRKDCPGR | |
| SCHEMBL24025263 | 0.97 | PLA2G2A (0.32) | PLA2G2APLA2G4APGRALDH1A1HPGD | |
| SCHEMBL24025163 | 0.96 | MAPT (0.32) | PLA2G2APLA2G4AGAAALDH1A1HPGD | |
| SCHEMBL22514403 | 0.93 | PLA2G2A (0.31) | PLA2G2APLA2G4A | |
| SCHEMBL22514701 | 0.93 | MAPT (0.30) | PLA2G2APLA2G4AALDH1A1HPGDTSHR | |
| SCHEMBL25660286 | 0.93 | PLA2G2A (0.32) | PLA2G2APLA2G4APLA2G10PRKDCL3MBTL1 | |
| SCHEMBL21147174 | 0.92 | PLA2G2A (0.32) | PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL24025269 | 0.92 | ALDH1A1 (0.36) | L3MBTL1ALDH1A1HPGDTSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210355128-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355128-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | NR2E3, CRY2, CRY1 | PLA2G2A 3269/4885PLA2G4A 2991/4885PLA2G10 3151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.